Extending time to disease progression or survival in cancer patients using her dimerization inhibitor本申请描述了通过用HER二聚化抑制剂诸如pertuzumab治疗患者,在癌症患者中延长病情进展前时间或存活,其中所述患者的癌症表现出HER活化. The present application describes by HER dimerization inhibitor such as ...
疾病进展时间,Time to progression disease progression疾病进展 1.Relationship between HIV-1 B′specific cytotoxic T lymphocytes and disease progression;HIV-1B′特异性细胞毒性T细胞与疾病进展关系 2.Several research groups have recently reported that persistent GB virus C(GBV-C) co-infected with human ...
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis If considered at the day of visit, then this is a potential over-estimation of time to progression. Bias can also be introduced by a visit schedule that is scheduled to the treatment needs--visits ...
关于至二次进展的时间 PFS2 ( Time to Second Disease Progression)的定义,以下描述最准确的是:A.从随机化分组开始,至因任何原因引起死亡的时间。B.从随机化分组开始,至出现影像学进展或因任何原因导致死亡的时间(以先发生的为准),对原发病灶、非区域淋巴结侵犯、
aThe time to radiologic progression was defined as the time from randomization to disease progression (according to RECIST) on the basis of independent radiologic review. Data from patients who died without tumor progression were censored.The disease-control rate was defined as the 正在翻译,请等待....
Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation ...
To observe the disease time to progression (TTP) obtained with fulvestrant when used on metastatic breast cancer as first-, second-, and also third-line therapy. We also aimed to correlate the TTP obtained with fulvestrant with hormone receptor, HER2 expression, and metastatic site. This was a...
“As observed in our global phase 3 ARCHES study, and now reaffirmed with China ARCHES, [enzalutamide] significantly delays the time to disease progression in men with mHSPC and may provide an important treatment option for men in China if approved.” Although it has not been approved by ...
Disease progression in time through presporulating (latent), sporulating (infectious) and postporulating (removal) stages has been modelled as a three-compartment system in the case where no upper bound for total disease increase is considered. Deterministic compartment analysis has been performed bas...
aPFS was defined as the time from randomization until disease progression or death from any cause within 90 days after the last tumor assessment or after randomization PFS是defined作为时间从随机化直到疾病进步或死亡从任何起因在90天之内在最后肿瘤评估以后或在随机化以后[translate]...